IGC Pharma Inc (IGC)
0.431
-0.03
(-5.61%)
USD |
NYAM |
Apr 24, 16:00
0.418
-0.01
(-3.02%)
After-Hours: 20:00
IGC Pharma Cash from Financing (TTM): 2.856M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.856M |
September 30, 2023 | 2.857M |
June 30, 2023 | 0.10M |
March 31, 2023 | 0.10M |
December 31, 2022 | 0.10M |
September 30, 2022 | 0.099M |
June 30, 2022 | 3.415M |
March 31, 2022 | 4.142M |
December 31, 2021 | 18.30M |
September 30, 2021 | 18.30M |
June 30, 2021 | 14.83M |
March 31, 2021 | 14.69M |
December 31, 2020 | 0.453M |
September 30, 2020 | 0.453M |
June 30, 2020 | 0.521M |
March 31, 2020 | -0.059M |
December 31, 2019 | 0.011M |
September 30, 2019 | 21.93M |
June 30, 2019 | 27.66M |
March 31, 2019 | 27.60M |
December 31, 2018 | 28.90M |
September 30, 2018 | 8.554M |
June 30, 2018 | 3.315M |
March 31, 2018 | 3.715M |
December 31, 2017 | 3.247M |
Date | Value |
---|---|
September 30, 2017 | 1.232M |
June 30, 2017 | 1.292M |
March 31, 2017 | 0.7076M |
December 31, 2016 | 1.157M |
September 30, 2016 | 1.580M |
June 30, 2016 | 0.3503M |
March 31, 2016 | 1.011M |
December 31, 2015 | -0.1893M |
September 30, 2015 | -0.2099M |
June 30, 2015 | 0.7119M |
March 31, 2015 | 2.900M |
December 31, 2014 | 4.062M |
September 30, 2014 | 4.497M |
June 30, 2014 | 4.334M |
March 31, 2014 | 1.736M |
December 31, 2013 | 0.5293M |
September 30, 2013 | 0.1528M |
June 30, 2013 | 0.019M |
March 31, 2013 | 0.0277M |
December 31, 2012 | -0.6393M |
September 30, 2012 | -0.6509M |
June 30, 2012 | -0.617M |
March 31, 2012 | -0.6258M |
December 31, 2011 | 0.5994M |
September 30, 2011 | 2.229M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.059M
Minimum
Mar 2020
27.66M
Maximum
Jun 2019
6.883M
Average
2.856M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
CEL-SCI Corp | 8.678M |
AIM ImmunoTech Inc | 0.485M |
NovaBay Pharmaceuticals Inc | 1.91M |
Protalix BioTherapeutics Inc | 24.67M |
Palatin Technologies Inc | 5.553M |